Stephen D. Stamatis
Eli Lilly (United States)(US)Lilly (China)(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Process Optimization and Integration, Drug Solubulity and Delivery Systems, Advanced Multi-Objective Optimization Algorithms, Analytical Chemistry and Chromatography
Most-Cited Works
- → New Sorbents for Desulfurization of Diesel Fuels via π Complexation: Layered Beds and Regeneration(2003)129 cited
- → Bayesian Framework for Building Kinetic Models of Catalytic Systems(2009)54 cited
- → Novel flexibility index formulations for the selection of the operating range within a design space(2021)25 cited
- → An optimization-based model discrimination framework for selecting an appropriate reaction kinetic model structure during early phase pharmaceutical process development(2021)16 cited
- → Flexibility index of black‐box models with parameter uncertainty through derivative‐free optimization(2021)15 cited
- → Novel formulations of flexibility index and design centering for design space definition(2022)15 cited
- → Design space description through adaptive sampling and symbolic computation(2022)10 cited
- → A Novel Method for Assessing Drug Degradation Product Safety Using Physiologically-Based Pharmacokinetic Models and Stochastic Risk Assessment(2015)9 cited
- → Polymorphic and Covalent Transformations of Gabapentin in Binary Excipient Mixtures after Milling-Induced Stress(2018)8 cited
- → Interaction between Permeation Enhancers and Lipid Bilayers(2024)7 cited